UK Gov. Agency Conducts Large Study--No Risk of Ischemic Stroke Post mRNA & Influenza Jab

British researchers from the UK Health Security Agency and the London School of Hygiene and Tropical Medicine declare in a research letter published in JAMA that according to their analysis of mRNA COVID-19 vaccination subjects, the jabs are not associated with an increase in the risk of stroke in the 21 days immediately after vaccination with either of the mRNA COVID-19 bivalent BA.1 vaccines (Pfizer-BioNTech or Modena) in England. Prominent UK authors Nick Andrews, Ph.D., Julia Stowe, Ph.D., Elizabeth Miller, MBBS and Mary Ramsay, MBBS point out they can find no risk for ischemic and hemorrhagic stroke associated with a subset of the study cohort (aged 65 and up given the influenza vaccine on the same day as the bivalent COVID-19 jab. 
The background